HomeNewsBusinessCompaniesAstraZeneca to conduct additional global trials of its potential COVID-19 vaccine

AstraZeneca to conduct additional global trials of its potential COVID-19 vaccine

After a preliminary analysis showed the drug to be 90% effective, there was an uproar among a section of scientists. AstraZeneca executives later said that high-efficacy dosage was an outcome of a dosing error. India is heavily relying on the success of AstraZeneca’s vaccine for a faster rollout.

Viswanath Pilla

November 27, 2020 / 20:13 IST

Story continues below Advertisement

Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.

first published: Nov 27, 2020 08:10 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

AstraZeneca to conduct additional global trials of its potential COVID-19 vaccine

After a preliminary analysis showed the drug to be 90% effective, there was an uproar among a section of scientists. AstraZeneca executives later said that high-efficacy dosage was an outcome of a dosing error. India is heavily relying on the success of AstraZeneca’s vaccine for a faster rollout.

News

Features

Tools

Specials

Network 18 Sites

Personal Finance

Quick Links